3
|
18
|
7b1hC |
Monoclinic p21 structure of human mad1 c-terminal domain in complex with phosphorylated bub1 cd1 domain |
5
|
19
|
7b1jC |
Orthorhombic p21212 structure of human mad1 c-terminal domain in complex with phosphorylated bub1 cd1 domain |
38
|
128
|
7e2kA |
Crystal structure of the rwd domain of human gcn2 - 1 |
270
|
946
|
7jweA |
Gedatolisib bound to the pi3kg catalytic subunit p110 gamma |
91
|
288
|
7l25A |
Hpk1 in complex with compound 18 |
3
|
21
|
7b1fC |
Orthorhombic p212121 structure of human mad1 c-terminal domain in complex with phosphorylated bub1 cd1 domain |
90
|
272
|
6xfpA |
Crystal structure of braf kinase domain bound to belvarafenib |
13
|
40
|
7nipA |
Titin n2a unique sequence (un2a) core |
115
|
355
|
7ncfA |
Crystal structure of hipk2 in complex with mu135 (compound 21e) |
106
|
322
|
6vxuA |
Structure of human vaccinia-related kinase 1 (vrk1) bound to ach471 |
79
|
231
|
6wqxC |
Human prpk-tprkb complex |
115
|
332
|
7b8iA |
Tetragonal structure of human protein kinase ck2 catalytic subunit in complex with a heparin oligo saccharide |
106
|
314
|
6kmhA |
The crystal structure of cask/mint1 complex |
79
|
273
|
6l17A |
Crystal structure of ser/thr kinase pim1 in complex with 10-debc derivatives |
20
|
133
|
7jhpC |
Crystal structure of hras in complex with the ras-binding and cysteine-rich domains of craf-kinase |
78
|
289
|
6vpjA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 c247v + c319v double mutant dephosphorylated, and in complex with amp-pnp |
74
|
262
|
6xkaA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 dephosphorylated, and coalated on c290 |
90
|
289
|
6vpmA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 with c290 disulfide bonded to compound 8-34, and in complex with amp-pnp |
79
|
290
|
6vphA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 modified with cacodylate and in complex with amp-pnp |
90
|
289
|
6vplA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 with c290 disulfide bonded to compound 7-80, and in complex with amp-pnp |
84
|
288
|
6vpiA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 c247v + d256n + c319v triple mutant disulfide homodimer in complex with amp-pnp |
85
|
288
|
6vpgA |
Tpx2 residues 7-20 fused to aurora a residues 116-389 in complex with amp-pnp |
657
|
2367
|
6z3aE |
Mec1-ddc2 (wild-type) in complex with amp-pnp |
626
|
2367
|
6z2wE |
Mec1-ddc2 (f2244l mutant) in complex with mg amp-pnp |
619
|
2367
|
6z2xE |
Mec1-ddc2 (f2244l mutant) in complex with mg amp-pnp (state ii) |
588
|
2533
|
6zwmA |
Cryo-em structure of human mtor complex 2, overall refinement |
1
|
28
|
6lphB |
The sufu-fu complex crystal structure |
92
|
296
|
6lxyA |
Irak4 in complex with inhibitor |
290
|
937
|
7k6nA |
Crystal structure of pi3kalpha selective inhibitor 11-1575 |
114
|
328
|
7a22A |
Crystal structure of human protein kinase ck2alpha' (csnk2a2 gene product) in complex with the atp-competitive inhibitor 5,6,7-tribromo-1h-triazolo[4,5-b]pyridine |
466
|
1759
|
6zwoB |
Cryo-em structure of human mtor complex 2, focused on one half |
81
|
280
|
7b30A |
Mst3 in complex with compound g-5555 |
74
|
306
|
7atuA |
The limk1 kinase domain bound to lijtf500025 |
80
|
281
|
7b33A |
Mst3 in complex with mria11 |
266
|
937
|
7k6oA |
Crystal structure of pi3kalpha inhibitor 10-5429 |
289
|
1328
|
7k10A |
Cryoem structure of activated-form fatkin domain of dna-pk |
298
|
1328
|
7k11A |
Cryoem structure of inactivated-form fatkin domain of dna-pk |
83
|
295
|
7c2wA |
Crystal structure of irak4 kinase in complex with a small molecule inhibitor |
82
|
281
|
7b34A |
Mst3 in complex with compound mria12 |
110
|
334
|
7a4cA |
Crystal structure of human protein kinase ck2alpha (csnk2a1 gene product) in complex with the atp-competitive inhibitor 5,6,7-tribromo-1h-triazolo[4,5-b]pyridine |
253
|
936
|
7k71A |
Crystal structure of pi3kalpha inhibitor 4-0686 |
75
|
266
|
7ayhA |
Crystal structure of aurora a in complex with 7-(2-anilinopyrimidin-4-yl)-1-benzazepin-2-one derivative (compound 2c) |
81
|
281
|
7b31A |
Mst3 in complex with compound mria9 |
70
|
307
|
7atsA |
The limk1 kinase domain bound to lijtf500127 |
117
|
328
|
7a1zA |
Crystal structure of human protein kinase ck2alpha' (csnk2a2 gene product) in complex with the atp-competitive inhibitor 6-bromo-5-chloro-1h-triazolo[4,5-b]pyridine |
101
|
297
|
7c2vA |
Crystal structure of irak4 kinase in complex with the inhibitor ca-4948 |
79
|
279
|
7b35A |
Mst3 in complex with compound mria13 |
90
|
293
|
7akgA |
Crystal structure of stk17b with bound dovitinib |
85
|
283
|
7b36A |
Mst4 in complex with compound g-5555 |
72
|
298
|
7kacA |
Crystal structure of hpk1 (map4k1) kinase in complex with 5-{[4-{[(1s)-2-hydroxy-1-phenylethyl]amino}-5-(1,3,4-oxadiazol-2-yl)pyrimidin-2-yl]amino}-3,3-dimethyl-2-benzofuran-1(3h)-one |